The Ear That Was Always a Gift

What's happening

On April 23, the FDA approved Otarmeni (lunsotogene parvec-cwha), the first-ever gene therapy for genetic hearing loss. Developed by Regeneron, the one-time treatment targets a rare form of deafness caused by mutations in the OTOF gene, which affects roughly 50 children born in the U.S. each year. Through a small incision behind the ear, surgeons infuse billions of engineered viruses carrying a healthy copy of the gene into the cochlea.

In the Phase 1/2 CHORD trial, 80% of 20 patients achieved significant hearing restoration. 42% reached normal hearing, including the ability to register whispers. Effects have lasted at least two years. Regeneron will provide the therapy free in the U.S.

Sierra Smith of East Greenbush, New York, described the moment her previously deaf son startled at her laugh in the car: "the most surreal moment a mother can feel." Historian Jaipreet Virdi, who is deaf, offered a counterweight, warning that such therapies can frame deafness as a problem requiring eradication.

What the Text says

The Gospel of Mark records a healing in the Decapolis where the crowd's reaction lands on a single sentence.

Mark 7:37They were astonished beyond measure, saying, "He has done all things well. He makes even the deaf hear, and the mute speak!"

The Greek word for "well" is kalōs, the same word the Septuagint uses to translate God's verdict over creation in Genesis 1: it was good. The crowd is not paying Jesus a compliment. They are quoting the creation story. They have recognized that whatever just happened in front of them belongs to the same category as the original making of the world.

Mark also preserves an unusual detail. Jesus sighs before he speaks. The verb is estenaxen, a deep groan, the same word Paul will later use in Romans 8 for creation itself groaning under brokenness. The text does not present the deaf man as defective. It presents the silence as something Jesus mourns alongside him before acting — though it is worth saying that this passage has been read in the opposite direction for centuries, marshalled as proof that Deafness is a condition Christ came to undo, and used against Deaf people in pedagogy, policy, and pulpit. The reading offered here is not the only one the text permits, and it is not the one that has done most of the historical work.

The single Aramaic word Jesus speaks, ephphatha, means simply "be opened." The verb is passive. Something is acted upon; something else does the acting. The healing is described as removing an obstruction, not as fixing a person. Whether what was removed was the man's deafness or the world's distance from him is a question the text leaves more open than its inheritors usually have.

The reflection

Otoferlin is a protein the size of a rumor. Without it, the inner hair cells cannot pass sound to the brain. A virus, harmless and patient, now carries the missing instruction back into the cochlea, and a child startles at his mother's laugh for the first time.

Jaipreet Virdi, the historian who pushed back on the news, is not arguing against Sierra Smith's son. She is arguing against a longer history. For two centuries, hearing-majority societies have used the language of medicine to describe Deafness as a defect requiring intervention, and the people doing the describing have rarely been Deaf. American Sign Language was banned from many schools well into the twentieth century on exactly these grounds. The arrival of an effective treatment does not end that argument; it sharpens it. When refusal becomes possible, refusal becomes legible, and a community that was simply itself becomes a community that has chosen something. That is not nothing.

Scripture is not outside this. The same passage in Mark has been read for centuries as evidence that Deafness is a condition Jesus came to undo, and that reading has been used against Deaf people in real ways — in policy, in pedagogy, in churches. The text does not require that reading. But the text has done that work in the world, and a faithful encounter with Mark 7 has to know it.

And yet the boy startled at his mother's laugh. The trial worked. The protein the size of a rumor reached the cell that was waiting for it.

The honest reading of Mark 7 does not collapse into either side of this. Jesus sighs before he speaks. He mourns the silence rather than treating it as a defect. He removes what was in the way — and the text is careful not to call what was in the way the man's identity. The healing is also a refusal: Jesus refuses to make the deaf man's deafness the meaning of him. The same refusal is what Virdi is asking for now.

What was opened in Galilee with a word is being opened now with a syringe. Whether that is the same act, or only the same verb, is a question the church has not finished asking.